Novel treatment approach to enable blood group-incompatible transplantations

Research Project
|
01.03.2021
- 28.02.2023

Transplant shortages have necessitated blood group-incompatible organ/stem cell transplantation. To ease organ deficit and improve patients' lives, we have designed glycopolymers to selectively remove circulating antibodies, reducing dependence on immunosuppresants and associated infection risk.

Funding

Novel treatment approach to enable ABO blood group incompatible solid organ and stem cell transplantations

Innosuisse Projekt (GrantsTool), 03.2021-02.2023 (24)

PI : Hevey, Rachel.
CI : Ricklin, Daniel.

Members (2)

Rachel Hevey

Principal Investigator

Daniel Ricklin

Co-Investigator

Research Groups

Molecular Pharmacy